ButanVac is being marketed as an 100-percent Brazilian vaccine. That is inaccurate, though. Photo: Will Oliver/Shutterstock
São Paulo’s Butantan Biological Institute announced it will begin production of its very own coronavirus vaccine, ButanVac. However, the institute still lacks regulatory approval to hold clinical trials on the immunizer. Federal regulator Anvisa suspended requests due to a lack of documentation.
Governor João Doria nevertheless called it “significant news for Brazilian and global science.” Butantan expects to produce 18 million doses in 2021.
The ButanVac uses technology developed by the New York-based Mount Sinai Health System and is being developed not only in Brazil, but also in Vietnam, Thailand, and Mexico. So far, the only 100-percent Latin American vaccine in development is Cuba’s Soberana 02.
Panama was once a part of Colombia. Its canal, a monumental engineering achievement of its…
The specialization trend among corporate board members It is not only a matter of perception:…
Panama will hold its presidential elections on Sunday, months after huge protests saw thousands descend…
The city of Rio de Janeiro estimates that a Madonna concert this Saturday on Copacabana…
Latin America’s trend of banning opposition candidates from elections has caught on in an ever-growing…
The São Paulo City Council on Thursday approved legislation authorizing Brazil’s largest city to sign…